Stay updated on Pembrolizumab for Mycosis Fungoides Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Mycosis Fungoides Clinical Trial page.

Latest updates to the Pembrolizumab for Mycosis Fungoides Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved the general government funding/status notice from the page; study details including eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check35 days agoChange DetectedResults for NCT03695471 have been posted, and the page now shows updated outcome measures and completion dates. Enrollment status and safety data sections appear updated accordingly.SummaryDifference0.4%

- Check63 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference2%

- Check71 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.SummaryDifference0.1%

- Check85 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2, signaling a new release; 'Back to Top' was removed as a minor UI change.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab for Mycosis Fungoides Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Mycosis Fungoides Clinical Trial page.